(CON) Concentra Holdings Parent - Ratings and Ratios

Concentra Group Holdings Parent, Inc. (NYSE:CON) is a leading provider of occupational health services in the United States, offering a comprehensive range of services designed to protect employees from workplace hazards and promote overall health and wellness. The companys services include workers compensation, employer-sponsored primary care, mobile health, and episodic specialty testing, as well as telemedicine, pharmacy, and medical compliance administration services.

In addition to its core occupational health services, Concentra provides a range of ancillary services, including injury care, primary care, urgent care, preventive care, clinical testing, physical examinations, and vaccinations. The companys consultative services help employers identify and mitigate workplace hazards, reducing the risk of injuries and illnesses. With a history dating back to 1979, Concentra has established itself as a trusted partner for employers seeking to promote a healthy and safe work environment.

From a technical analysis perspective, Concentras stock price is currently trading near its 20-day simple moving average (SMA) of $21.87, indicating a stable trend. The stocks 50-day SMA and 200-day SMA are also in close proximity, suggesting a lack of significant price momentum. However, the average true range (ATR) of 0.51, representing a 2.36% daily price range, indicates moderate volatility. Given the current technical setup, it is likely that the stock will continue to trade within a narrow range in the near term.

Fundamentally, Concentras market capitalization of $2.77 billion and price-to-earnings (P/E) ratio of 15.76 suggest a stable and relatively attractive valuation. The companys forward P/E ratio of 16.00 indicates expected earnings growth, while its return on equity (RoE) of 33.92% demonstrates strong profitability. Based on these fundamental metrics, it is likely that Concentra will continue to experience steady earnings growth, driving the stock price higher in the long term.

Forecasting Concentras stock price using a combination of technical and fundamental data, I would expect the stock to trade within a range of $20.50 to $23.50 over the next quarter. The stocks stable technical trend, combined with its attractive valuation and strong profitability, suggest a moderate upside potential. As the company continues to expand its services and promote a healthy and safe work environment, I would forecast a long-term target price of $28.00, representing a potential upside of 28% from current levels.